Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Patients' characteristics.

From: The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders

Parameters Patients with liver diseases* (n = 423) Patients with coincidence of AIH and any kind of liver disorder (n = 24)** Patients with AIH/overlap syndromes (n = 10) Patients with coincidence of AIH and other liver disease (n = 14) Patients with AIH (n = 43)
Gender (F/M) 231/192 12/12 5/5 7/7 33/10
Age mean ± SD (years) 51.6 ± 22.7 54.9 ± 18.6 49.6 ± 21.6 57.7 ± 15.5 52.3 ± 15.7
Serum globulin or IgG above normal (pos/neg; pos = score ≥ 1) 202/221 17/7 7/3 10/4 34/9
Alcohol abuse (>60 g/day: yes/no) 98/325 3/21 0/10 3/11 1/42
Drug use (yes/no) 25/398 0/24 0/10 0/14 1/42
Other autoimmune diseases (yes/no) 24/399 7/17 5/5 2/12 18/25
ANA or SMA or anti-LKM (pos/neg) (positive titre ≥ 1:40) 335/88 23/1 9/1 14/0 43/0
AMA (pos/neg) 49/374 4/20 4/6 0/14 0/43
Histology (pos/neg) (pos = score > 0, neg = score ≤ 0) 58/365 13/11 3/7 10/4 35/8
   Total histologic score ± SD -4 ± 3.3 0.38 ± 3.72 -2.1 ± 4.4 2.14 ± 1.7 2.73 ± 1.98
   Median (range) -5 (-11 to +5) 1 (-8 to +4) 0 (-8 to +4) 3 (0 to +4) 3 (-3 to +5)
  1. Abbreviations are same as in text. *Excluding AIH patients (n = 43) and patients with coincidence of AIH and any kind of liver disorder (n = 24); **Means the coexistence of AIH with any kind of other liver disease; M = male; F = female.